Get notified when DNTH files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: DNTH Dianthus Therapeutics, Inc. /DE/ 8-K

Dianthus shareholders elect directors, approve executive pay and auditor at annual meeting

Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read

Key Changes

  • low

    Anne McGeorge re-elected to Class II board seat with 80.5% support (34.8M for, 8.4M withheld), notably lower than co-directors Kango (98.9%) and Violin (99.0%).

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Say-on-pay approved with 95.9% support (41.0M for, 1.7M against), reflecting routine shareholder endorsement of executive compensation practices.

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →
  • low

    Deloitte & Touche ratified as 2026 auditor with 99.99% approval (46.3M for, 5,279 against).

    Item 5.07 — Submission of Matters to a Vote of Security Holders verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade DNTH commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify